Peng Zhao

10PUBLICATIONS
75CO-AUTHORS
Tumour immunologyMolecular targetsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 09, 2026
Spatiotemporal mapping of tertiary lymphoid structure heterogeneity shapes immune niches and clinical outcomes in intrahepatic cholangiocarcinoma.

|Jul 30, 2026
Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in patients with Advanced Hepatocellular Carcinoma.

|Mar 10, 2026
AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling.

Chuan Liu, Chuan Hu, Jinlin Cheng

|Feb 27, 2026
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial.

Yang Gao, Jie Li, Hangyu Zhang

|Mar 06, 2024
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells.

Jiaqi Shi, Wei Wu, Dong Chen

|Feb 23, 2024
Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma.

Yuzhi Jin, Hui Ren, Qianhua Yue

Pageof 2

Frequent Collaborators

8 joint publications

Weijia Fang

5 joint publications

Xuanwen Bao

5 joint publications

Xiaomeng Dai

4 joint publications

Bin Li